The profile of the expression of the immune response genes in the vagina of women in the complex therapy of recurrent vulvovaginal candidiasis

Host immunity against Candida albicans is crucial in controlling C. albicans infection. The innate immunity is believed to be the first line of host defense, such as the direct killing of yeasts through phagocytosis by neutrophils and macrophages. In addition to innate immune cells, an adjunctive pro...

Full description

Bibliographic Details
Main Authors: Sh M Pogosyan, E A Mezhevitinova, P R Abakarova, A E Donnikov, V V Muravyova
Format: Article
Language:Russian
Published: IP Berlin A.V. 2017-06-01
Series:Гинекология
Subjects:
Online Access:https://gynecology.orscience.ru/2079-5831/article/viewFile/28627/pdf
_version_ 1818210616146395136
author Sh M Pogosyan
E A Mezhevitinova
P R Abakarova
A E Donnikov
V V Muravyova
author_facet Sh M Pogosyan
E A Mezhevitinova
P R Abakarova
A E Donnikov
V V Muravyova
author_sort Sh M Pogosyan
collection DOAJ
description Host immunity against Candida albicans is crucial in controlling C. albicans infection. The innate immunity is believed to be the first line of host defense, such as the direct killing of yeasts through phagocytosis by neutrophils and macrophages. In addition to innate immune cells, an adjunctive protective effect is played by cellular adaptive immunity represented by Th lymphocytes. The balance of various Th cell subpopulations plays a crucial role in regulating the prognosis of C. albicans infection. Yeasts cell recognition by pattern recognition receptors leads to proinflammatory cytokines synthesis, cause immune system activation and yeast cells killing. However it was demonstrated that C. albicans inhibits immune response which cause infection. Aim - studying vaginal microbiota and the local immune response in women with recurrent vulvovaginal candidiasis for improving the tactics of their management. Results. Our date demonstrates that vaginal disbiosis are risk factor for RVVC and leads to more active innate immune system response.
first_indexed 2024-12-12T05:19:26Z
format Article
id doaj.art-7e88a4ca4108454d86d033edfa153222
institution Directory Open Access Journal
issn 2079-5696
2079-5831
language Russian
last_indexed 2024-12-12T05:19:26Z
publishDate 2017-06-01
publisher IP Berlin A.V.
record_format Article
series Гинекология
spelling doaj.art-7e88a4ca4108454d86d033edfa1532222022-12-22T00:36:39ZrusIP Berlin A.V.Гинекология2079-56962079-58312017-06-01193495425757The profile of the expression of the immune response genes in the vagina of women in the complex therapy of recurrent vulvovaginal candidiasisSh M Pogosyan0E A Mezhevitinova1P R Abakarova2A E Donnikov3V V Muravyova4V.I.Kulakov Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian FederationV.I.Kulakov Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian FederationV.I.Kulakov Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian FederationV.I.Kulakov Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian FederationV.I.Kulakov Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian FederationHost immunity against Candida albicans is crucial in controlling C. albicans infection. The innate immunity is believed to be the first line of host defense, such as the direct killing of yeasts through phagocytosis by neutrophils and macrophages. In addition to innate immune cells, an adjunctive protective effect is played by cellular adaptive immunity represented by Th lymphocytes. The balance of various Th cell subpopulations plays a crucial role in regulating the prognosis of C. albicans infection. Yeasts cell recognition by pattern recognition receptors leads to proinflammatory cytokines synthesis, cause immune system activation and yeast cells killing. However it was demonstrated that C. albicans inhibits immune response which cause infection. Aim - studying vaginal microbiota and the local immune response in women with recurrent vulvovaginal candidiasis for improving the tactics of their management. Results. Our date demonstrates that vaginal disbiosis are risk factor for RVVC and leads to more active innate immune system response.https://gynecology.orscience.ru/2079-5831/article/viewFile/28627/pdfvulvovaginal candidiasisrecurrent vulvovaginal candidiasistreatment of vulvovaginal candidiasisimmune response to vulvovaginal candidiasisgenes expression profile during vulvovaginal candidiasis
spellingShingle Sh M Pogosyan
E A Mezhevitinova
P R Abakarova
A E Donnikov
V V Muravyova
The profile of the expression of the immune response genes in the vagina of women in the complex therapy of recurrent vulvovaginal candidiasis
Гинекология
vulvovaginal candidiasis
recurrent vulvovaginal candidiasis
treatment of vulvovaginal candidiasis
immune response to vulvovaginal candidiasis
genes expression profile during vulvovaginal candidiasis
title The profile of the expression of the immune response genes in the vagina of women in the complex therapy of recurrent vulvovaginal candidiasis
title_full The profile of the expression of the immune response genes in the vagina of women in the complex therapy of recurrent vulvovaginal candidiasis
title_fullStr The profile of the expression of the immune response genes in the vagina of women in the complex therapy of recurrent vulvovaginal candidiasis
title_full_unstemmed The profile of the expression of the immune response genes in the vagina of women in the complex therapy of recurrent vulvovaginal candidiasis
title_short The profile of the expression of the immune response genes in the vagina of women in the complex therapy of recurrent vulvovaginal candidiasis
title_sort profile of the expression of the immune response genes in the vagina of women in the complex therapy of recurrent vulvovaginal candidiasis
topic vulvovaginal candidiasis
recurrent vulvovaginal candidiasis
treatment of vulvovaginal candidiasis
immune response to vulvovaginal candidiasis
genes expression profile during vulvovaginal candidiasis
url https://gynecology.orscience.ru/2079-5831/article/viewFile/28627/pdf
work_keys_str_mv AT shmpogosyan theprofileoftheexpressionoftheimmuneresponsegenesinthevaginaofwomeninthecomplextherapyofrecurrentvulvovaginalcandidiasis
AT eamezhevitinova theprofileoftheexpressionoftheimmuneresponsegenesinthevaginaofwomeninthecomplextherapyofrecurrentvulvovaginalcandidiasis
AT prabakarova theprofileoftheexpressionoftheimmuneresponsegenesinthevaginaofwomeninthecomplextherapyofrecurrentvulvovaginalcandidiasis
AT aedonnikov theprofileoftheexpressionoftheimmuneresponsegenesinthevaginaofwomeninthecomplextherapyofrecurrentvulvovaginalcandidiasis
AT vvmuravyova theprofileoftheexpressionoftheimmuneresponsegenesinthevaginaofwomeninthecomplextherapyofrecurrentvulvovaginalcandidiasis
AT shmpogosyan profileoftheexpressionoftheimmuneresponsegenesinthevaginaofwomeninthecomplextherapyofrecurrentvulvovaginalcandidiasis
AT eamezhevitinova profileoftheexpressionoftheimmuneresponsegenesinthevaginaofwomeninthecomplextherapyofrecurrentvulvovaginalcandidiasis
AT prabakarova profileoftheexpressionoftheimmuneresponsegenesinthevaginaofwomeninthecomplextherapyofrecurrentvulvovaginalcandidiasis
AT aedonnikov profileoftheexpressionoftheimmuneresponsegenesinthevaginaofwomeninthecomplextherapyofrecurrentvulvovaginalcandidiasis
AT vvmuravyova profileoftheexpressionoftheimmuneresponsegenesinthevaginaofwomeninthecomplextherapyofrecurrentvulvovaginalcandidiasis